Okuläres vernarbendes Schleimhautpemphigoid – ein Fallbericht

• Literatur

• 1 Rübsam A, Klein JP, Pleyer U. Das okuläre vernarbende Pemphigoid – aktuelle Aspekte zu Klinik und Therapie einer problematischen Erkrankung. Klin Monatsbl Augenheilkd 2013; 230: 796-803
• 2 Queisi MM, Zein M, Lamba N. et al. Update on ocular cicatricial pemphigoid and emerging treatments. Surv Ophthalmol 2016; 61: 314-317
• 3 Neff AG, Turner M, Mutasim DF. Treatment strategies in mucous membrane pemphigoid. Ther Clin Risk Manag 2008; 4: 617-626
• 4 Chan LS. Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid). Clin Dermatol 2012; 30: 34-37
• 5 Chan LS, Majmudar AA, Tran HH. et al. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 1997; 108: 848-853
• 6 Ong HS, Setterfield JF, Minassian DC. et al. Mucous membrane pemphigoid with ocular involvement: the clinical phenotype and its relationship to direct immunofluorescence findings. Ophthalmology 2018; 125: 496-504
• 7 Hübner F, Recke A, Zillikens D. et al. Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol 2016; 136: 2495-2498
• 8 Fremont F, Pelissier-Suarez C, Fournié P. et al. Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review. Cornea 2019; 38: 1406-1411
• 9 Murrell DF, Marinovic B, Caux F. et al. Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J Am Acad Dermatol 2015; 72: 168-174
• 10 Elder MJ, Bernauer W, Leonard J. et al. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 1996; 80: 292-296
• 11 Ahmed M, Zein G, Khawaja F. et al. Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res 2004; 23: 579-592